Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system
- PMID: 2973152
Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system
Abstract
Platelet factor 4 (PF4) and beta thromboglobulin (beta TG) are platelet-specific proteins which are released upon platelet aggregation and which can be accurately measured by radioimmunoassay. We devised a catheter-infusion system that enables serial determinations of these proteins. In 20 subjects (10 healthy volunteers and 10 patients with stable coronary artery disease), we compared samples collected by individual venipunctures with those simultaneously obtained by means of a simple catheter-infusion system. At least 5 samples were obtained over a period of time which was as long as 60 min, and at least 30 min. Subjects with stable coronary artery disease were selected so that they would be expected to have stable and normal PF4 and beta TG levels. Thus, elevations of either PF4 or beta TG would represent artifacts secondary to sampling technique. Analysis of the results demonstrated that the catheter-infusion system was equivalent to individual venipunctures for determination of PF4 and beta TG. 16.8% of samples obtained via the catheter and 17.2% of those obtained by individual venipunctures were spuriously elevated. A second series of studies were performed to refine the technique further by examining the impact of infusion rate and the addition of citrate phosphate dextrose (CPD) to the infusate. Ten additional subjects had catheter systems utilized in both arms simultaneously. The addition of CPD resulted in significantly less abnormal values at slower infusion rates (1 and 2.5 cc/min). At 5 cc/min D5/w or saline alone are suitable. These investigations confirm that this simple catheter system is equivalent to individual venipunctures for determination of PF4 and beta TG while avoiding patient discomfort.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.Semin Thromb Hemost. 1993;19 Suppl 1:178-82. Semin Thromb Hemost. 1993. PMID: 8362264
-
Beta-thromboglobulin (beta tg) and platelet factor 4 (PF4) in patients with myeloproliferative diseases.Thromb Haemost. 1994 Sep;72(3):484-6. Thromb Haemost. 1994. PMID: 7710537 No abstract available.
-
Serial studies of platelet factor 4 and beta thromboglobulin during exercise in patients with coronary artery disease.Am Heart J. 1985 Aug;110(2):293-9. doi: 10.1016/0002-8703(85)90147-4. Am Heart J. 1985. PMID: 2411121
-
Platelet-released proteins as molecular markers for the activation process.Semin Thromb Hemost. 1984 Oct;10(4):270-9. doi: 10.1055/s-2007-1004432. Semin Thromb Hemost. 1984. PMID: 6240116 Review.
-
Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders?Ric Clin Lab. 1984 Jan-Mar;14(1):9-18. doi: 10.1007/BF02905035. Ric Clin Lab. 1984. PMID: 6203164 Review.
Cited by
-
Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex.Ann Hematol. 1993 Sep;67(3):121-5. doi: 10.1007/BF01701734. Ann Hematol. 1993. PMID: 8373897 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous